I. INTRODUCTION {#acm20176-sec-0001}
===============

Intensity‐modulated radiation therapy (IMRT) has become a standard technique in radiation therapy to provide more conformal dose distribution to improve tumor control probability and/or to reduce radiation toxicities. Currently, more than approximately half of every disease sites use IMRT.^(^ [^1^](#acm20176-bib-0001){ref-type="ref"} ^--^ [^4^](#acm20176-bib-0004){ref-type="ref"} ^)^ For some simple cases, such as localized prostate cancer or whole breast irradiation, various class solutions or protocols can be developed to generate an IMRT plan efficiently.^(^ [^5^](#acm20176-bib-0005){ref-type="ref"} ^)^ However, for complicated cases such as some of head and neck cancers, it is still time‐consuming to generate optimized IMRT plans. Besides requirements of accurate delineations of various target volumes and organs at risk (OAR), it is often required to generate additional IMRT optimization structures such as dose limiting ring structures, manually selecting beam directions and energies, IMRT objectives and associated weights. These parameters are generally adjusted manually during the optimization process with trial and error approach, including adding additional IMRT objectives to reduce various cold and hot spots in the dose distribution.

There are on‐going research activities to find more efficient ways for IMRT planning.^(^ [^6^](#acm20176-bib-0006){ref-type="ref"} ^--^ [^12^](#acm20176-bib-0012){ref-type="ref"} ^)^ Multicriteria optimization technique^(^ [^13^](#acm20176-bib-0013){ref-type="ref"} ^--^ [^20^](#acm20176-bib-0020){ref-type="ref"} ^)^ has been introduced into IMRT planning in order to help solve issues faced with single objective planning where a weight for each objective needs to be set before the plan can be optimized. However, currently, it is still time‐consuming with multicriteria optimization to generate and navigate through a large number of plans in Pareto surface. Recently, multicriteria optimization has been commercialized in RaySearch Laboratories\' planning system (RaySearch Laboratories, Stockholm, Sweden).^(^ [^21^](#acm20176-bib-0021){ref-type="ref"} ^)^

Regional optimization^(^ [^22^](#acm20176-bib-0022){ref-type="ref"} ^)^ is an effective way to improve IMRT plans by emphasizing specific region of interests to help create high‐dose gradients between target volumes and critical structures during optimization using relatively high importance factors on small region of interests. In this study, we present an iterative method that can be incorporated in clinical process to improve IMRT plan quality and efficiency. Specifically, we have implemented regional optimization in a simple iterative algorithm in a commercial treatment planning system (Pinnacle, Philips Radiation Oncology, Fitchburg, USA). The regional optimization we implemented is based on region of interest (ROI), and is not voxel‐based, as in the original paper.^(^ [^22^](#acm20176-bib-0022){ref-type="ref"} ^)^ Our method is based on automatically generated cold and hot regions in the plan. In this work, we demonstrate that such iterative algorithm is applicable to clinical sites that are generally more challenging in IMRT planning. The method was applied to three clinical sites: head and neck, prostate with pelvic nodes, and anal canal cancers, where we evaluated its efficacies and time savings. In principal, this method can also be used for other sites to automate IMRT planning processes using planning scripts in treatment planning systems.

II. MATERIALS AND METHODS {#acm20176-sec-0002}
=========================

A. Overview {#acm20176-sec-0003}
-----------

For each clinical site, a class solution was first developed manually based on a group of clinical cases. The class solution provides standard beam parameters such as number of beams, their energies, directions, collimator angles, jaw positions, and initial IMRT objectives and corresponding weights. After a class solution was developed for a clinical site, the entire optimization process was incorporated in a planning script. The planning script includes the major activities shown in Fig. [1](#acm20176-fig-0001){ref-type="fig"}. For the purpose of providing concrete methodologies, we will explain each of the optimization steps using the National Cancer Institute of Canada Clinical Trials Group head and neck clinical protocol (NCIC CTG HN.6) as an example. This is a good clinical site to illustrate how to automate regional IMRT optimization with many OARs and multiple target volumes. We will also present our evaluation of this technique on two other clinical sites: high risk prostate cancer requiring pelvic nodes radiation and anal canal cancers also with substantial nodal irradiations. Details for automated IMRT planning for these sites are given in the [Appendices](#acm20176-app-0001){ref-type="app"}.

![An overview of the steps completed by each script for a clinical site.](ACM2-14-176-g001){#acm20176-fig-0001}

B. Check required regions of interest {#acm20176-sec-0004}
-------------------------------------

The IMRT scripts require basic regions of interests (ROIs) to be defined, such as all clinical target volumes (CTVs) and all organs at risk (OARs). For example, for the NCIC CTG HN.6, the following ROIs are required: CTV70, CTV63 and/or CTV56, where 70, 63, and 56 are the prescription dose in units of Gray for each volume, with intended doses delivered in 35 fractions. Other required ROIs are: cord, brain_stem, right parotid (rt_parotid), left parotid (lt_parotid), larynx, mandible, rt_cochlea, lt_cochlea, oral_cavity, and one for the body contour (external). Standard nomenclature is required by the script.

It is important to ensure all the required ROIs are present, so that the script can set proper IMRT objectives for these ROIs. The script will check for the required dose matrix and ROIs. If any of the ROIs are missing, it will display names of missing ROIs, in order for a user to add or correct the names of required ROIs. If all the required ROIs are present, the script will set standard colors for ROIs to facilitate quality assurance.

C. Generate additional contours {#acm20176-sec-0005}
-------------------------------

After checking for the required ROIs, the iterative algorithm will generate various derived contours such as planning target volume (PTV) for each CTV, planning organ‐at‐risk volumes (PRVs) for required OARs, and various dose‐limiting ring structures for IMRT optimization purpose. For the head and neck IMRT clinical trial, Table [1](#acm20176-tbl-0001){ref-type="table-wrap"} gives a summary of all the contours generated.

###### 

Summary of all the contours generated for HN6 clinical trial.

  *Contour Name*   *Explanations*                                                    *Contour Name*   *Explanations*
  ---------------- ----------------------------------------------------------------- ---------------- ------------------------------------------------------------------
  PTV70            Planning target volumes for 70, 63 and 56 Gy prescription doses   TPTV             Total sum of all PTVs
  PTV63                                                                              cord prv         Planning risk volumes for cord and brainstem with a 5 cm uniform
  PTV56                                                                              brainstem prv    margin
  modPTV70         PTVs that exclude cord_prv, brainstem_prv and not closer to       rt parotid opt   Parotid volumes avoiding PTVs
  modPTV63         the external contour by 5 mm                                      lt parotid opt   
  modPTV56                                                                           external 5mm     Body contour with a 5 mm margin
  optPTV63         Optimization PTVs, avoiding overlap volumes with higher           ring70           1 cm ring around PTV70
  optPTV56         prescription doses                                                ring63           1 cm ring around ring70, and PTV63
  optPTV63 m       Optimization PTVs, avoiding overlap volumes with higher           ring56           1 cm ring around ring63, and PTV56
  optPTV56 m       prescription doses with a 1 cm margin                             ring50           1 cm ring around ring56

The script generates derived ROIs for OARs, such as cord_prv and brainstem_prv with 5 mm margin from cord and brain stem, respectively. Other generated PTVs are modPTV70, modPTV63, and/or modPTV56 that exclude cord_prv, brainstem_prv, and are away from skin by a 5 mm margin. Their purposes are to limit the dose to spinal cord and brain stem to within tolerance and reducing skin dose. Also, it generates optPTV63 and/or optPTV56 that avoids overlapping with higher dose PTVs, such as $\text{optPTV}63 = \text{modPTV}63 - \text{modPTV}70$ for optimization purpose. Rings with 1 cm uniform margin around PTVs and/or other rings, such as ring70, ring63, and/or ring56, are created for creating a more conformal dose distribution by specifying a maximum dose in each ring structure. In order to reduce dose to critical structures such as the parotids, rt_parotid_opt and lt_parotid_opt are generated that avoid the PTVs so that more realistic objectives for IMRT optimization can be set. Total sum of the PTVs, TPTV, is generated in order to help define optimal beam geometries.

D. Add beams {#acm20176-sec-0006}
------------

A summary of the six different fields used for HN.6 with their respective couch, gantry, and collimator angles is given in Table [2](#acm20176-tbl-0002){ref-type="table-wrap"}. Beams are added according to the class solution with fixed jaw sizes based on the PTV coverage and OAR sparing to reduce local minimum problem in IMRT optimization and to improve delivery accuracy and efficiency. TPTV (defined previously) is used to adjust beam geometry that covers the desired volumes. Beam geometry is set by setting the collimator, gantry, and couch angles, and setting the jaw sizes. The jaw sizes for LAO and RAO fields in Table [2](#acm20176-tbl-0002){ref-type="table-wrap"} were set to cover the total PTV with 8 mm margin, but it is limited to less than 14.5 cm in order to avoid beam splitting on Varian linacs. Thus, only the side of TPTV where beam direction is along the boundary of TPTV and parotids is made sure to be covered by the fields so that the field edge can provide higher dose gradient between TPTV and parotids. This jaw size is also set to avoid junction of the multileaf collimator (MLC) inside the fields to reduce delivery uncertainty. However, two noncoplanar beams, LSAO and RSAO, are added to cover the whole TPTV with fixed jaw size to avoid beam splitting and to provide dose gradients required for both sides of TPTV. The use of noncoplanar beams is to cover lower neck nodes but avoid irradiation to shoulders. The advantage of using fixed jaw size for large IMRT target volumes in the head and neck was discussed in a recent publication.^(^ [^23^](#acm20176-bib-0023){ref-type="ref"} ^)^ As shown in Fig. [2](#acm20176-fig-0002){ref-type="fig"}, two posterior oblique fields cover the PTVs only from one side and shield part of the post neck region with only 2 cm jaw position from central axis for easier MLC segmentation to reduce dose to spinal cord and brain stem.

###### 

Summary of beams generated for HN.6.

                                           *Gantry Angle*   *Collimator Angle*   *Couch Angle*
  ---------------------------------------- ---------------- -------------------- ---------------
  LSAO (left superior anterior oblique)    75°              0°                   15°
  LAO (left anterior oblique)              15°              15°                  0°
  LPO (left posterior oblique)             148°             350°                 0°
  RPO (right posterior oblique)            218°             10°                  0°
  RAO (right anterior oblique)             285°             0°                   345°
  RSAO (right superior anterior oblique)   345°             350°                 0°

![Jaw positions for IMRT fields are fixed in the script to reduce probability of local minimum to avoid beam splitting for more accurate and efficient radiation delivery.](ACM2-14-176-g002){#acm20176-fig-0002}

After the beam geometry is defined, the proper dose prescription is set. In the case of HN.6, the prescription dose is 70 Gy in 35 fractions to a reference point at the center of GTV. The script will check for the position of the isocenter; this isocenter will be used in all beams. The isodose lines will also be set using standard percentages of prescription with standard colors.

A similar procedure was carried out to implement class solutions ([Appendices A](#acm20176-app-0001){ref-type="app"} and [B](#acm20176-app-0001){ref-type="app"}) for the high risk prostate cancer and anal canal cancer cases.

E. Initial optimization {#acm20176-sec-0007}
-----------------------

IMRT parameters are set in the script, including the maximum number of iterations, the maximum number of control points, minimum segment MU, and area. Then, IMRT objectives and their respective weights are set for the initial optimization using direct machine parameter optimization (DMPO) in Pinnacle. The IMRT objectives used for HN.6 are given in Table [3](#acm20176-tbl-0003){ref-type="table-wrap"}. Higher weights are given to minimum dose of CTVs and modified or optimization

###### 

Some of the IMRT objectives set for the first optimization for HN.6.

  *ROI Name*       *Objective Type*   *Dose (cGy)*   *Weight*
  ---------------- ------------------ -------------- ----------
  CTV56            Minimum dose       5700           100
  CTV63            Minimum dose       6350           100
  CTV70            Minimum dose       7100           10
  modPTV70         Maximum dose       7690           100
  modPTV70         Minimum dose       7000           65
  optPTV63         Maximum dose       6720           70
  optPTV63         Minimum dose       6450           80
  optPTV63_m       Uniform dose       6550           5
  optPTV56         Minimum dose       5700           100
  optPTV56_m       Maximum dose       6125           100
  optPTV56_m       Uniform dose       5650           1
  PTV56            Minimum dose       2800           1
  PTV63            Minimum dose       3200           1
  PTV70            Minimum dose       3000           30
  brainstem        Maximum dose       5000           100
  brainstem_prv    Maximum dose       5500           33
  cord             Maximum dose       4000           100
  cord_prv         Maximum dose       4500           70
  mandible         Maximum dose       7000           100
  lt_parotid_opt   Maximum EUD        2350           20
  ring50           Maximum dose       5000           10
  ring56           Maximum dose       5600           100
  ring63           Maximum dose       6300           50
  ring70           Maximum dose       7000           100

PTVs (modPTV70, optPTV63. and optPTV56) to ensure proper dose coverage of CTVs and PTVs that are away from skin by 5 mm. However, we specified lower maximum doses with low weights to the original PTVs to ensure that MLC will open around PTVs, since part of PTVs may be too close or outside patient skin. This will ensure sufficient skin flashing without unnecessary high skin dose. If any CTV is right on the skin, bolus will be used to make sure proper dose coverage. After IMRT objectives are specified, the dose is calculated and the first optimization is then started.

F. Regional optimization {#acm20176-sec-0008}
------------------------

We implemented the regional optimization to reduce hot and cold spots in IMRT dose distributions automatically in a simple iterative manner.

### F.1 Generating regional cold and hot spots {#acm20176-sec-0009}

After initial IMRT optimization and the final dose calculation using collapsed cone convolution for the first pass, various isodose lines related to the minimum doses to PTVs, maximum doses inside or outside PTVs are converted to contours in the iterative algorithm. Then, the corresponding cold or hot spots in each region are generated, such as in HN.6, cold56, cold63, cold70 for cold spot in optTV56, optPTV63, and modPTV70, respectively. Each cold spot is automatically generated in the script by subtracting the required minimum isodose line (converted to contour) from the target volume. For example, $\text{cold70} = \text{modPTV}70 - 70\,\text{Gy}$ isodose line. Similarly, hot56, hot63, hot70, hot_out_70 is the hot spot in optPTV56, optPTV63, PTV70, and outside PTV70, respectively, and they are generated automatically by the script. For example, $\text{hot}63 = \text{maximum}$ isodose line allowed in $\text{PTV}63 - \text{PTV}70 - \text{ring}70$. The reason to subtract higher dose ring ROIs is to avoid conflict with minimum dose coverage of higher dose PTVs. The regional cold and hot spots for HN.6 clinical protocol are listed in Table [4](#acm20176-tbl-0004){ref-type="table-wrap"} with their relations to various ROIs and isodose lines. Similar cold and hot spots based on the prescription of each PTV are added for prostate with pelvic nodes and anal canal cases.

###### 

Summary of regional cold and hot spots for HN.6 clinical protocol.

  *ROI Name*   *Relation to ROI of Isodose Lines*
  ------------ ---------------------------------------------------------
  hot_out_70   70 Gy isodose line ‐ PTV70 ‐ ring70
  hot63        69.3 Gy isodose line ‐ PTV70 ‐ ring70
  hot56        61.6 Gy isodose line ‐ PTV70 ‐ PTV63 ‐ ring70 ‐ ring 63
  hot70        75.6 Gy isodose line
  cold70       modPTV70 ‐ 70 Gy isodose line
  cold63       optPTV63 ‐ 63 Gy isodose line
  cold56       optPTV56 ‐ 56 Gy isodose line

### F.2 Iterative optimization with regional cold and hot spots {#acm20176-sec-0010}

IMRT objectives for these cold and hot spots are then added for regional optimization in the scripts --- for example, objectives listed in Table [5](#acm20176-tbl-0005){ref-type="table-wrap"} for HN.6 protocol. The IMRT plan is then continually optimized with these added regional objectives based on previously optimized and segmented plan using DMPO. In this re‐optimization, only MLC segment shape and weights are re‐optimized. The HN.6 script uses 20 iterations. The generation of various hot or cold spots and re‐optimization can be repeated multiple times until an optimal plan is achieved.

###### 

Summary of objectives set for the regional optimization for HN.6 clinical protocol.

  *ROI Name*   *Objective Type*   *Dose (cGy)*   *Weight*
  ------------ ------------------ -------------- ----------
  hot_out_70   Maximum dose       6800           100
  hot63        Maximum dose       6650           50
  hot56        Maximum dose       5880           5
  hot70        Maximum dose       7350           1
  cold70       Minimum dose       7000           100
  cold63       Minimum dose       6300           50
  cold56       Minimum dose       5600           10

III. RESULTS {#acm20176-sec-0011}
============

The method has been implemented and tested for three clinical sites: a clinical trial protocol for head and neck cancer, prostate cancer with pelvic nodes, and anal canal cancer. Figure [3](#acm20176-fig-0003){ref-type="fig"} shows DVH comparison for a head and neck case between a previously manually optimized clinical plan and the automatically optimized IMRT plan using the automatic iterative method. A manually optimized plan was used for comparison in this study and the plan was previously optimized by an experienced dosimetrist for clinical use. As shown in Fig. [3](#acm20176-fig-0003){ref-type="fig"}, the automatically generated plan has lower dose to the three most sensitive critical structures: brainstem, spinal cord, and the left and right parotids with similar PTV coverage. The comparison of dose distributions on an axial slice is shown in Fig. [4](#acm20176-fig-0004){ref-type="fig"}, showing fewer hot spots in the automatically optimized plan.

![DVH comparison for a head and neck case between manually (dashed line) and automatically generated plans (solid line).](ACM2-14-176-g003){#acm20176-fig-0003}

![Comparison of dose distribution on a transverse slice for a head and neck case between manually generated IMRT plan and automatically generated IMRT plan using the iterative method. Red shaded volume is PTV70 covered by 70 Gy isodose line in blue, and green shaded volume is PTV63 covered by 63 Gy isodose line in black.](ACM2-14-176-g004){#acm20176-fig-0004}

The results for prostate case with pelvic nodes are shown in Fig. [5](#acm20176-fig-0005){ref-type="fig"} for DVH comparison and Fig. [6](#acm20176-fig-0006){ref-type="fig"} for comparison in dose distributions. It shows that the automatically generated plan is similar to the manually generated clinical plan.

![DVH comparison for a prostate case with pelvic nodes irradiation between manually (dashed line) and automatically generated IMRT plans (solid line).](ACM2-14-176-g005){#acm20176-fig-0005}

![Comparison of dose distribution on a coronal slice for a prostate case with pelvic nodes between manually and automatically generated IMRT plans. Red shaded volume is PTV76 for prostate covered by 76 Gy isodose line shown in dark blue and purple shaded volume is PTV45 for pelvic nodes covered by 45 Gy isodose line shown in light blue.](ACM2-14-176-g006){#acm20176-fig-0006}

The results for an anal canal clinical case are shown in Fig. [7](#acm20176-fig-0007){ref-type="fig"} for DVH comparison and Fig. [8](#acm20176-fig-0008){ref-type="fig"} for comparison in dose distributions. It shows automatically generated plan is slightly worse than the manually optimized clinical plan in terms of dose coverage to PTV54 and dose conformality around PTV36.

![DVH comparison for an anal canal irradiation between manually (dashed line) and automatically generated IMRT plans (solid line).](ACM2-14-176-g007){#acm20176-fig-0007}

![Comparison of dose distributions on a transverse and a sagittal slice for anal canal case between manually and automatically generated IMRT plans. Red, pink, and blue shaded volumes are PTV36, PTV45, and PTV54, respectively, covered by the isodose line 36 Gy shown in green, 45 Gy shown in purple, and 54 Gy shown in blue, respectively.](ACM2-14-176-g008){#acm20176-fig-0008}

As an example, the effect of regional optimization is shown in Fig. [9](#acm20176-fig-0009){ref-type="fig"} for comparison of dose distributions before and after regional optimization using the cold and hot spots for a head and neck case.

![Comparison of dose distribution on the coronal slice for a head and neck case before (left) and after (right) automated regional optimization. Shaded volumes are PTV70 (blue), PTV63 (green), and PTV56 (red), respectively.](ACM2-14-176-g009){#acm20176-fig-0009}

The time required to run the planning script on a Pinnacle thin client using computation server with 4 quad core 2.9 GHz CPU is listed in Table [6](#acm20176-tbl-0006){ref-type="table-wrap"}. The estimated minimum time required for manual planning includes time needed to generate various derived contours, set up beams, dose prescription, manually and repeatedly adjust IMRT objectives, and running IMRT optimization. It shows that the iterative method implemented here as a script can save significant time in IMRT planning. These IMRT planning scripts are used clinically in our center for more than 500 clinical cases since they were implemented clinically in 2010. They include at least 300 head and neck, 180 prostate, and 20 anal canal cases. It should be noted that after using automated planning scripts, most cases will be tweaked by dosimetrists to see if further improvements can be made. However, most tweaking just needs a few more passes of the continuous optimization that usually take less than an hour. The estimated time saved in planning for each case is at least 2 hours for head and neck, and 1 hour for anal canal or prostate with pelvic nodes, depending on the experience of the planner.

###### 

Estimated time required to generate IMRT plans.

                               *Manual Planning*      *Automated Planning*
  ---------------------------- ---------------------- ----------------------
  Head and Neck                $> \, 4\,\text{hrs}$   $\sim 8\,\min$
  Anal Canal                   $> \, 2\,\text{hrs}$   $\sim 6\,\min$
  Prostate with Pelvic Nodes   \> 1.5 hrs             $\sim 6\,\min$

IV. DISCUSSION {#acm20176-sec-0012}
==============

The present work implemented planning scripts for complex IMRT cases that automated most aspects of plan optimization which otherwise required continual manual input by a planner. We used Pinnacle planning script to automate the regional optimization in an iterative manner; however, the concept can be used in other planning systems, as well. Automated IMRT planning script was recently published for optimization of breast radiotherapy with tangential beams.^(^ [^5^](#acm20176-bib-0005){ref-type="ref"} ^)^ Here, we present an automated planning process for more complicated head and neck, prostate with pelvic nodes, and anal canal cases. It also includes the method to automatically reduce various cold and hot spots in the optimization process. To our knowledge, such implementation for more complex IMRT cases has not been published before. Since the focus of this paper is on the methodology, we only present one example for each clinical site, even though the scripts have been used clinically for more than 500 cases. The thorough statistical analysis of these clinical cases will be presented in a separate paper.

Since many IMRT planning steps are included in our IMRT planning scripts, they generally save many hours in the IMRT planning process. It also helps implement clinical protocols, in‐house standards, using standard dose prescriptions, standard margin for PTVs, standard derived region of interests (ROIs), such as modPTVs, optPTVs, cord_prv, and brainstem_prv, as well as standard color scheme for ROIs and isodose lines. The planning script can reduce variations of plan quality due to different experience of planners. The planning scripts can be improved during clinical use, incorporating new techniques learned in practice.

For many complicated cases, the IMRT planning scripts provide only a good starting point; an optimal plan still requires a planner to fine‐tune the automatically generated plan to adapt the plan for individual situation. Also, the class solution does not consider geometry variations across patients; therefore, it requires fine‐tuning for each individual patient. Such fine‐tuning includes modifying IMRT objectives and their weights. Occasionally, beam parameters may also need to be modified, such as gantry or collimator angles. In future work we will investigate the impact of adjusting IMRT objectives and weights during the iterative optimization process. The regional optimization method presented in this paper may also be combined with priority‐based IMRT optimization method.^(^ [^24^](#acm20176-bib-0024){ref-type="ref"} ^)^

V. CONCLUSIONS {#acm20176-sec-0013}
==============

We have developed IMRT planning scripts for a few clinical sites to automate most of IMRT planning process. In particular, regional optimization has been implemented in an iterative algorithm to reduce hot or cold spots during the optimization process, especially important for complex cases. We demonstrated that this is particularly useful in IMRT planning for head and neck and prostate with pelvic nodes. We have shown that automated iterative inverse planning improves IMRT planning efficiency substantially.
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Appendix A. Prostate with pelvic nodes. {#acm20176-sec-0015}
=======================================

In this appendix we give some details on IMRT planning for prostate with pelvic nodes.

The prescription is 76 Gy for the prostate and 50.4 Gy for the pelvic nodes in 35 fractions. The contours generated by the script are listed in Table [7](#acm20176-tbl-0007){ref-type="table-wrap"}.

###### 

Summary of all the contours generated for prostate with pelvic nodes.

  *Contour Name*   *Explanations*                                                               *Contour Name*   *Explanations*
  ---------------- ---------------------------------------------------------------------------- ---------------- --------------------------------------
  PTV76            Planning target volumes for                                                  TPTV             Total sum of all PTVs
  PTV50.4          doses                                                                        ring76           1 cm ring around PTV76
  optPTV50.4       Optimization PTVs, avoiding overlap volumes with higher prescription doses   ring50.6         1 cm ring around ring76, and PTV50.6
                                                                                                ring3            1 cm ring around ring50.6

Six IMRT beams were used for IMRT planning, as listed in Table [8](#acm20176-tbl-0008){ref-type="table-wrap"}. Two of the beams (LAO2 and RAO2) cover both PTVs in order to ensure dose coverage, while the rest of the beams are set at a maximum field size of 14.5 cm to avoid junction of the MLC inside the fields for Varian machines.

###### 

Summary of beams generated for prostate with pelvic nodes.

                                    *Gantry Angle*   *Collimator Angle*   *Couch Angle*
  --------------------------------- ---------------- -------------------- ---------------
  LAO2 (left anterior oblique 2)    80°              348°                 0°
  LAO (left anterior oblique)       15°              0°                   0°
  LPO (left posterior oblique)      135°             340°                 0°
  RPO (right posterior oblique)     218°             10°                  0°
  RAO (right anterior oblique)      225°             20°                  0°
  RAO2 (right anterior oblique 2)   280°             13°                  0°

After the contours and the beams are generated, the plan is optimized using the IMRT objectives and weights shown in Table [9](#acm20176-tbl-0009){ref-type="table-wrap"}.

###### 

Some of the IMRT objectives set for the first optimization for prostate with pelvic nodes.

  *ROI Name*   *Objective Type*   *Dose (cGy)*   *Weight*
  ------------ ------------------ -------------- ----------
  CTV76        Minimum dose       7600           100
  optPTV50_4   Maximum dose       6000           20
  PTV50_4      Minimum dose       5040           40
  PTV76        Uniform dose       7650           5
  PTV76        Minimum dose       7600           35
  Bladder      Maximum EUD        4500           1
  Bladder      Maximum dose       7550           10
  Bowel        Maximum dose       5040           100
  Femur_LT     Maximum dose       4000           10
  Femur_RT     Maximum dose       4000           10
  Rectum       Maximum dose       7500           10
  Rectum       Maximum EUD        4500           1
  ring76       Maximum dose       7500           1
  ring50.4     Maximum dose       5000           1
  ring3        Maximum dose       4000           2

After the first pass of IMRT optimization, the cold and hot spots are generated automatically, as displayed in Table [10](#acm20176-tbl-0010){ref-type="table-wrap"}.

###### 

Summary of regional cold and hot spots for prostate with pelvic nodes.

  *ROI Name*   *Relation to ROI of Isodose Lines*
  ------------ ------------------------------------
  max79        80 Gy isodose line
  ptv_cold     PTV76 ‐ 72.2 Gy isodose line

The IMRT plan will be continually optimized with the new contours with the IMRT objectives listed in Table [11](#acm20176-tbl-0011){ref-type="table-wrap"}.

###### 

Summary of objectives set for the regional optimization for prostate with pelvic nodes.

  *ROI Name*   *Objective Type*   *Dose (cGy)*   *Weight*
  ------------ ------------------ -------------- ----------
  max78        Maximum dose       7900           40
  ptv_cold     Minimum dose       7350           40

Appendix B. Anal canal. {#acm20176-sec-0017}
=======================

There are multiple IMRT planning scripts generated for anal cancer with a total of ten different variations based on the stage, number of target volumes, and different prescriptions. There are minor deviations between each script due to different treatment types. As an example, this Appendix gives some details for the situation with dose prescription of 54 Gy to the primary tumor volume, 45 Gy, and 36 Gy to different nodal volumes given in 30 fractions.

After checking required contours, the automated IMRT script generates additional contours, as shown in Table [12](#acm20176-tbl-0012){ref-type="table-wrap"}.

###### 

Summary of all the contours generated for anal canal cancer case.

  *Contour Name*    *Explanations*                                                               *Contour Name*    *Explanations*
  ----------------- ---------------------------------------------------------------------------- ----------------- ----------------------------------------
  PTV54             Planning target volumes for 54, 45 and 36 Gy                                 TPTV              Total sum of all PTVs
  PTV45             prescription doses                                                           external 5mm      Body contour with a 5 mm margin
  PTV36                                                                                                            
  PTV54 eval        PTVs that exclude the external contour by 5 mm                               small bowel opt   Normal structure volumes avoiding PTVs
  PTV45 eval                                                                                     Bladder opt       
  PTV36 eval                                                                                     Perineum opt      
  ptv45 eval M      Optimization PTVs, avoiding overlap volumes with higher                      ring54            1 cm ring around PTV54
  ptv36 eval M      prescription doses and rings                                                 ring45            1 cm ring around ring54, and PTV45
  ptv45 eval only   Optimization PTVs, avoiding overlap volumes with higher prescription doses   ring36            1 cm ring around ring45, and PTV36

Six beams were used for IMRT planning. as listed in Table [13](#acm20176-tbl-0013){ref-type="table-wrap"}. Two of the posterior beams (LPO2 and RPO2) cover all the target volume, while the rest of the beams have a maximum field size of 14.5 cm.

###### 

Summary of beams generated for anal canal.

                                     *Gantry Angle*   *Collimator Angle*   *Couch Angle*
  ---------------------------------- ---------------- -------------------- ---------------
  LAO (left anterior oblique)        195°             10°                  0°
  LPO (left posterior oblique)       335°             0°                   0°
  LPO2 (left posterior oblique 2)    280°             0°                   0°
  RPO (right posterior oblique)      25°              0°                   0°
  RPO2 (right posterior oblique 2)   75°              0°                   0°
  RAO (right anterior oblique)       165°             350°                 0°

Some of the IMRT objectives used by the plan automation are shown in Table [14](#acm20176-tbl-0014){ref-type="table-wrap"}.

###### 

Some of the IMRT objectives set for the first optimization for case of anal canal cancer.

  *ROI Name*        *Objective Type*   *Dose (cGy)*   *Weight*
  ----------------- ------------------ -------------- ----------
  GTV               Uniform dose       5450           1
  PTV54_eval        Minimum dose       5400           80
  PTV54_eval        Maximum dose       5600           40
  PTV54_eval        Uniform dose       5500           10
  PTV45_eval        Minimum dose       4550           80
  ptv45_eval_M      Uniform dose       4600           40
  ptv45_eval_M      Maximum dose       4900           100
  ptv45_eval_only   Maximum dose       5300           5
  PTV36_eval        Minimum dose       3600           80
  ptv36_eval_M      Maximum dose       3900           100
  ptv36_eval_M      Uniform dose       3700           5
  Bladder_opt       Maximum dose       4300           50
  Perineum_opt      Maximum dose       4300           10
  Perineum_opt      Maximum EUD        4000           50
  small_bowel_opt   Maximum dose       4500           15
  small_bowel_opt   Maximum EUD        2800           1
  Femur_RT          Maximum dose       4700           1
  Femur_LT          Maximum dose       4700           1
  right54           Maximum dose       5400           10
  ring45            Maximum dose       4500           10
  ring36            Maximum dose       3600           5

After the first pass of IMRT optimization, cold and hot spots were generated using the isodose lines, as shown in Table [15](#acm20176-tbl-0015){ref-type="table-wrap"}.

###### 

Summary of regional cold and hot spots for anal canal cancer case.

  *ROI Name*   *Relation to ROI of Isodose Lines*
  ------------ ------------------------------------------------------------------
  hotspots     54 Gy isodose line ‐ PTV54_eval ‐ ring54
  hot54        58 Gy isodose line
  hot45        49.5 Gy isodose line ‐ PTV54_eval ‐ ring54
  hot36        39.6 Gy isodose line ‐ PTV45_eval ‐ PTV54_eval ‐ ring54 ‐ ring45
  cold36       PTV36_eval ‐ 36 Gy isodose line
  cold45       PTV45_eval ‐ 45 Gy isodose line
  cold54       PTV54_eval ‐ 54 Gy isodose line

IMRT objectives were added for these hot and cold spots, as shown in Table [16](#acm20176-tbl-0016){ref-type="table-wrap"}.

###### 

Summary of final objectives set for the regional optimization for anal canal cancer.

  *ROI Name*   *Objective Type*   *Dose (cGy)*   *Weight*
  ------------ ------------------ -------------- ----------
  hot54        Maximum dose       5670           10
  hot45        Maximum dose       4700           1
  hot36        Maximum dose       3780           1
  hotspots     Maximum dose       4800           2
  cold54       Minimum dose       5400           35
  cold45       Minimum dose       4500           60
  cold36       Minimum dose       3600           20
